Effects of nasal continuous positive airway pressure treatment on oxidative stress and adiponectin levels in obese patients with obstructive sleep apnea

Respiration

Volumn 79, Issue 5, 2010, Pages 370-376

  De Lima, Anna Myrna Jaguaribe ^a   Franco, Clélia Maria Ribeiro ^b   De Castro, Célia Maria MacHado Barbosa ^c   Bezerra, Alice De Andrade ^c   Ataíde Jr , Luiz ^b   Halpern, Alfredo ^d  

^a UNIVERSIDADE FEDERAL RURAL DE PERNAMBUCO   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c Keizo Asami Immunopathology Laboratory   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adiponectin; Insulin resistance; Obesity; Obstructive sleep apnea; Oxidative stress

Indexed keywords

ADIPONECTIN; NITRATE; NITRITE; SUPEROXIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; OBESITY; OXIDATIVE STRESS; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; SYNTHESIS;

ADIPONECTIN; CASE-CONTROL STUDIES; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; NITRATES; NITRITES; OBESITY; OXIDATIVE STRESS; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; SUPEROXIDES;

EID: 77951298524     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000227800     Document Type: Article

References (40)

1. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667-689.
2. Keaney JF Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ; Framingham Study: Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003; 23: 434-439. (Pubitemid 36337219)
3. Viinikka L: Nitric oxide as a challenge for the clinical chemistry laboratory. Scand J Clin Lab Invest 1996; 56: 577-581. (Pubitemid 26423582)
4. Vettor R, Milan G, Rossato M, Federspil G: Adipocytokines and insulin resistance. Aliment Pharmacol Ther 2005; 22: 3-10.
5. Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB, Chen C: Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J Surg Res 2005; 126: 121-129. (Pubitemid 40726256)
6. Krakoff J, Funahashi T, Stehouwer CD, Schalkwijk CG, Tanaka S, Matsuzawa Y, Kobes S, Tataranni PA, Hanson RL, Knowler WC, Lindsay RS: Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care 2003; 26: 1745-1751. (Pubitemid 36929114)
7. Wright J, Johns R, Watt I, Melville A, Sheldon T: Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence. Br Med J 1997; 314: 851-860. (Pubitemid 27182017)
8. Jenkinson C, Davies RJ, Mullins R, Stradling JR: Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep CPAP in sleep apnoea: a randomised prospective parallel trial. Lancet 1999; 353: 2100-2105. (Pubitemid 29278478)
9. Hsu AAL, Lo C: Continuous positive airway pressure therapy in sleep apnoea. Respirology 2003; 8: 447-454. (Pubitemid 38009638)
10. Yee B, Liu P, Phillips C, Grunstein R: Neuroendocrine changes in sleep apnea. Curr Opin Pulm Med 2004; 10: 475-481. (Pubitemid 39441440)
11. Ip MS, Lam B, Chan LY, Zheng L, Tsang KW, Fung PC, Lam WK: Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000; 162: 2166-2171. (Pubitemid 32051681)
12. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, Seeger W, Grimminger F: Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000; 162: 566-570. (Pubitemid 30647201)
13. Brooks B, Cistulli PA, Borkman M, Ross G, Mcghee S, Grunstein RR, Sullivan CE, Yue DK: Obstructive sleep apnea in obese noninsulin- dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 1994; 79: 1681-1685.
14. Harsch IA, Koebnick C, Wallaschofski H, Ficker, JH, Lohmann T, Konturek PC: Resistin levels in patients with obstructive sleep apnoea syndrome - the link to subclinical inflammation? Med Sci Monit 2004; 10: CR510-CR515. (Pubitemid 39278559)
15. Harsch IA, Konturek PC, Koebnick C, Kuehnlein PP, Fuchs FS, Pour Schahin S, Wiest GH, Hahn EG, Lohmann T, Ficker JH: Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 2003; 22: 251-257. (Pubitemid 36986993)
16. Narkiewicz K, Somers SK: Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand 2003; 177: 385-390. (Pubitemid 36337642)
17. Geloneze B, Repetto EM, Geloneze SR, Tambascia MA, Ermetice MN: The threshold value for insulin resistance (HOMA IR) in an admixtured population IR in the Brazilian Metabolic Syndrome Study. Diabetes Res Clin Pract 2006; 72: 219-220.
18. Geloneze B, Tambascia MA: Avaliação laboratorial e diagnóstico da resistência insulínica. Arq Bras Endocrinol Metab 2006; 50: 208-215. (Pubitemid 43799107)
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistence and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
20. Ikeda Y, Suehiro T, Nakamura T, Kumon Y, Hashimoto K: Clinical significance of the insulin resistance index as assessed by homeostasis model assesment. Endocr J 2001; 48: 81-86. (Pubitemid 32230388)
21. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I: Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-1761. (Pubitemid 40385531)
22. Magalang UJ, Rajappan R, Hunter MG, Kutala VK, Kuppusamy P, Wewers MD, Marsh CB, Parinandi NL: Adiponectin inhibits superoxide generation by human neutrophils. Antioxid Redox Signal 2006; 8: 2179-2186. (Pubitemid 46489642)
23. Makino S, Handa H, Suzukawa K, Fujiwara M, Nakamura M, Muraoka S, Takasago I, Tanaka, Y, Hashimoto, K, Sugimoto T: Obstructive sleep apnoea syndrome, plasma adiponectin levels and insulin resistance. Clin Endocrinol 2006; 64: 12-19.
24. Wolk R, Svatikova A, Nelson CA, Gami AS, Govender K, Winnicki M, Somers VK: Plasma levels of adiponectin, a novel adipocytederived hormone, in sleep apnea. Obes Res 2005; 12: 186-190.
25. Zhang XL, Yin KS, Mao H, Wang H, Yang Y: Serum adiponectin level in patients with obstructive sleep apnea hypopnea syndrome. Chin Med J (Engl) 2004; 117: 1603-1606. (Pubitemid 39619232)
26. Masserini B, Morpurgo PS, Donadio F, Baldessari C, Bossi R, Beck-Peccoz P, Orsi E: Reduced levels of adiponectin in sleep apnea syndrome. J Endocrinol Invest 2006; 29: 700-705. (Pubitemid 44756174)
27. Ip MS, Lam B, Ng MMT, Lam WK, Tsang KWT, Lam KSL: Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165: 670-676. (Pubitemid 34194755)
28. West SD, Nicoll DJ, Stradling JR: Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax 2006; 61: 945-950.
29. Weaver TE: Adherence to positive airway pressure therapy. Curr Opin Pulm Med 2006; 12: 409-413. (Pubitemid 44624599)
30. Campos-Rodriguez F, Pena-Grinan N, Reyes-Nunez N, et al: Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest 2005; 128: 624-633. (Pubitemid 41140489)
31. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE; Sleep Heart Health Study Investigators: Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004; 160: 521-530. (Pubitemid 44138807)
32. Larsen JJ, Hansen JM, Olsen NV, et al: The effect of altitude hypoxia on glucose homeostasis in men. J Physiol (Lond) 1997; 504: 241-249.
33. 1-adrenergic blockade reduces insulin sensitivity. J Appl Physiol 2001; 91: 623-631. (Pubitemid 32681090)
34. Wolk R, Shamsuzzaman ASM, Somers VK: Obesity, sleep apnea, and hypertension. Hypertension 2003; 42: 1067-1074. (Pubitemid 37549057)
35. Fletcher EC, Orolinova N, Bader M: Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system. J Appl Physiol 2002; 92: 627-633. (Pubitemid 34671030)
36. Mantzoros CS: The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 1999; 130: 671-680.
37. Matsumura K, Tsuchihashi T, Fujji K, Iida M: Neural regulation of blood pressure by leptin and related peptides. Reg Pep 2003; 114: 79-86. (Pubitemid 36773870)
38. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R: Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett 2001; 507: 142-146. (Pubitemid 33001531)
39. Punjabi NM, Sorkin JD, Karzel LI, Goldberg AP, Schwartz AR, Smith PL: Sleepdisordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002; 165: 677-682.
40. Gruber A, Horwood F, Sithole J, Ali NJ, Idris I: Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol 2006; 5: 22. (Pubitemid 44781864)